HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT05916339

AWARE: Management of ADHD in Autism Spectrum Disorder

A short description of this study’s research objective has not yet been verified.

Medication studyAges 4–17Canada + United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 4 years to 17 years.

Listed locations
Irvine, United States · Los Angeles, United States and 11 more locationsSee all locations and recruitment
Activities
Medication described in the protocol
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
500
Sponsor
Daniel Coury
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States, Canada
Age range
From 4 Years to 17 Years
Official registry ID
NCT05916339
Official title
Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder

Want help reviewing this study?

Loading the security check...
Study ID: NCT05916339. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Irvine, United States · Los Angeles, United States · Portland, United States

10 more locations
  • Boston, United States
  • Rochester, United States
  • Cincinnati, United States
  • Columbus, United States
  • Philadelphia, United States
  • Pittsburgh, United States
  • Greenville, United States
  • Charlottesville, United States
  • Edmonton, Canada
  • Toronto, Canada
Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Daniel Coury.

Does this study involve medication?

Yes. The study involves medication, including Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant..

Who can participate?

Listed age limits: 4 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.